Hinge Health, Inc. (HNGE) is a publicly traded Healthcare sector company. As of May 21, 2026, HNGE trades at $55.84 with a market cap of $4.23B and a P/E ratio of -5.08. HNGE moved -0.64% today. Year to date, HNGE is +16.77%; over the trailing twelve months it is flat. Its 52-week range spans $30.08 to $62.18. Analyst consensus is strong buy with an average price target of $68.15. Rallies surfaces HNGE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Analysts See 39% Upside in Hinge Health as EPS Estimates Climb 63%: Shares of Hinge Health have gained 0.4% over the past four weeks to $41.92, while analysts’ mean price target of $58.25 implies a 39% upside. The 16 short-term targets carry a $6.92 standard deviation and consensus EPS forecasts for the year have jumped 63.2%.
| Metric | Value |
|---|---|
| Price | $55.84 |
| Market Cap | $4.23B |
| P/E Ratio | -5.08 |
| EPS | $-10.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $62.18 |
| 52-Week Low | $30.08 |
| Volume | 568 |
| Avg Volume | 0 |
| Revenue (TTM) | $646.34M |
| Net Income | $-510.27M |
| Gross Margin | 80.80% |
13 analysts cover HNGE: 0 strong buy, 13 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $68.15.